Edition:
United States

CVS Health Corp (CVS)

CVS on New York Consolidated

77.66USD
18 Aug 2017
Change (% chg)

$-1.23 (-1.56%)
Prev Close
$78.89
Open
$78.45
Day's High
$78.75
Day's Low
$77.55
Volume
5,005,371
Avg. Vol
5,841,142
52-wk High
$98.44
52-wk Low
$69.30

CVS

Chart for CVS

About

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $78,946.41
Shares Outstanding(Mil.): 1,016.57
Dividend: 0.50
Yield (%): 2.58

Financials

  CVS Industry Sector
P/E (TTM): 15.48 21.18 41.42
EPS (TTM): 5.02 -- --
ROI: 8.05 11.92 63.99
ROE: 15.36 13.59 75.97

CVS Health's dull third-quarter forecast overshadows profit beat

CVS Health Corp forecast current quarter profit below Wall Street estimates and said it has been ordered to cooperate with investigations into possible false claims submitted to a government healthcare program and drug pricing.

Aug 08 2017

UPDATE 3-CVS Health's dull Q3 forecast overshadows profit beat

* Shares down 1.4 pct (Adds investor comment, company response; updates shares)

Aug 08 2017

BRIEF-CVS Health received civil investigative demand from Attorney General of Minnesota

* CVS Health Corp - in July 2017, co received a civil investigative demand from the attorney general of Minnesota - sec filing

Aug 08 2017

BRIEF-CVS Health reports Q2 GAAP earnings per share $1.07 from continuing operations

* Q2 gaap earnings per share $1.07 from continuing operations

Aug 08 2017

CVS Health's quarterly profit jumps 19 pct

Aug 8 CVS Health Corp, the No.2 U.S. drugstore chain by store count, reported an 18.8 percent rise in quarterly profit on Tuesday, as its pharmacy benefits management business serviced more claims and demand for its specialty pharmacy services rose.

Aug 08 2017

BRIEF-Wellcare Health Plans CFO says company and CVS Health have agreed to extend their pharmacy benefit manager agreement for 2019 and 2020

* Wellcare Health Plans CFO says company and CVS Health have agreed to extend their pharmacy benefit manager agreement for 2019 and 2020 - Conf Call Further company coverage:

Aug 04 2017

Two biggest U.S. drug purchasers keep key Novo Nordisk drugs on 2018 list

COPENHAGEN, Aug 2 U.S. pharmacy benefit manager (PBM), CVS Health, said late Tuesday it had kept Novo Nordisk's key drugs on its 2018 list, removing some uncertainty over the U.S. market for the world's top insulin maker.

Aug 02 2017

BRIEF-Orexo says Zubsolv gains preferred position on CVS Caremark 2018 formulary

* Zubsolv gains preferred position on CVS Caremark 2018 formulary

Aug 02 2017

CVS to pay $5 million to resolve U.S. drug probe

CVS Health Corp has paid $5 million to resolve allegations that pharmacies it operates in California failed to keep and maintain accurate records of prescription drugs, the U.S. Justice Department said on Tuesday.

Jul 11 2017

CVS to pay $5 million to resolve U.S. drug probe

CVS Health Corp has paid $5 million to resolve allegations that pharmacies it operates in California failed to keep and maintain accurate records of prescription drugs, the U.S. Justice Department said on Tuesday.

Jul 11 2017

Earnings vs. Estimates